Sunny Xu Zhu

Sunny Zhu currently serves as the Chief Medical Officer at Everest Medicines since October 2017, focusing on anti-infectious diseases. Previously, Sunny held various leadership roles at Bayer Pharmaceuticals, where as Global Clinical Lead, management of an anti-infective compound's global clinical development program was a key responsibility. At AstraZeneca, notable positions included Executive Director for Drug Development, where involvement in global project teams based in the UK was significant, and Regional Clinical Project Director for AsiaPac focusing on Respiratory and CNS therapeutic areas. Early career at Merck Sharp & Dohme involved leading local clinical design and study operations in China. Sunny holds a Master of Medical Science in Biostatistics and Study Design, along with a Master's in Medicine and Public Health from Peking University.